Patterns of anti-tuberculosis drug resistance among HIV-infected patients in Maputo, Mozambique, 2002-2003

SETTING: Two tuberculosis (TB) reference hospitals in Maputo, Mozambique.OBJECTIVES: To assess the pattern of TB drug resistance and its risk factors in human immunodeficiency virus (HIV) patients.DESIGN: Adult HIV-positive patients with TB diagnosed by culture of sputum or bronchial washing were en...

Full description

Saved in:
Bibliographic Details
Published inThe international journal of tuberculosis and lung disease Vol. 9; no. 5; pp. 494 - 500
Main Authors NUNES, E. A, DE CAPITANI, E. M, COELHO, E, JOAQUIM, O. A, FIGUEIREDO, I. R. O, COSSA, A. M, PANUNTO, A. C, CARVALHO-RAMOS, M
Format Journal Article
LanguageEnglish
Published Paris, France IUATLD 01.05.2005
Union internationale contre la tuberculose et les maladies respiratoires
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:SETTING: Two tuberculosis (TB) reference hospitals in Maputo, Mozambique.OBJECTIVES: To assess the pattern of TB drug resistance and its risk factors in human immunodeficiency virus (HIV) patients.DESIGN: Adult HIV-positive patients with TB diagnosed by culture of sputum or bronchial washing were enrolled during 2002-2003. Cultures of 111 patients were tested for rifampicin, isoniazid, streptomycin and ethambutol sensitivity. Chest X-ray, haemoglobin (Hb), total lymphocyte and CD4 counts were also performed.RESULTS: Overall resistance to any drugs was found in 18% and multidrug-resistant TB (MDR-TB) in 9%. New cases of TB accounted for 62% of the studied group. Drug resistance in this subgroup was 13% compared with 26.3% in the previously treated subgroup, and MDR-TB was 5.8% vs. 15.8%. All patients presented Hb levels <9 g/dl and total lymphocyte counts <1200/μl. CD4 counts were significantly low in the drug resistance subgroup, with levels mostly <100/μl. Cavities on X-ray were seen only in drug-sensitive patients. No risk factors for drug resistance were detected.CONCLUSIONS: Overall observed drug resistance was 18%, and MDR-TB 9%. Previously treated patients had high drug resistance (26.3%) and MDR-TB (15.8%).
Bibliography:(R) Medicine - General
1027-3719(20050501)9:5L.494;1-
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:1027-3719
1815-7920